Best practice: Refrigerate after opening
By including all English-language studies on muscle mass loss during GLP-1RA therapy in T2D and obesity from major scientific databases and clinical trial registries, this narrative review synthesizes the current knowledge on the epidemiology and mechanisms of muscle loss in diabetes and obesity, with a focus on the impact of GLP-1RAs therapy
They may be able to help you develop a dosing plan that reduces the risk of potential interactions
This form is taken once daily, with a recommended starting dose of 3 mg per day for the first 30 days
Yan, T., Liu, B., Wang, N., Liao, Z., Wu, B., He, B., & Jia, Y